In ‘Major Milestone,’ FDA Approves First Cell Therapy for Solid Tumors

Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the FDA for advanced melanoma.